KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueGoodwillGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNon-Current Deffered RevenueOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Blackbaud (BLKB) Cash & Equivalents (2016 - 2025)

Historic Cash & Equivalents for Blackbaud (BLKB) over the last 17 years, with Q3 2025 value amounting to $419.2 million.

  • Blackbaud's Cash & Equivalents fell 208.13% to $419.2 million in Q3 2025 from the same period last year, while for Sep 2025 it was $419.2 million, marking a year-over-year decrease of 208.13%. This contributed to the annual value of $741.9 million for FY2024, which is 643.87% up from last year.
  • As of Q3 2025, Blackbaud's Cash & Equivalents stood at $419.2 million, which was down 208.13% from $870.2 million recorded in Q2 2025.
  • Blackbaud's 5-year Cash & Equivalents high stood at $870.2 million for Q2 2025, and its period low was $216.1 million during Q3 2021.
  • Its 5-year average for Cash & Equivalents is $499.8 million, with a median of $428.1 million in 2024.
  • As far as peak fluctuations go, Blackbaud's Cash & Equivalents surged by 6936.69% in 2023, and later crashed by 208.15% in 2024.
  • Quarter analysis of 5 years shows Blackbaud's Cash & Equivalents stood at $596.6 million in 2021, then increased by 17.7% to $702.2 million in 2022, then fell by 0.75% to $697.0 million in 2023, then grew by 6.44% to $741.9 million in 2024, then crashed by 43.5% to $419.2 million in 2025.
  • Its Cash & Equivalents stands at $419.2 million for Q3 2025, versus $870.2 million for Q2 2025 and $419.4 million for Q1 2025.